Contributor Page
Akin Gump Strauss Hauer & Feld LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 310 229 1000
Fax: +1 310 229 1001
2029 Century Park East Suite 2400
Los Angeles
CA 90067-3010
United States
By Spencer S. Griffith, Bernd Janzen, Stephen Kho, Hal Shapiro, Kevin Wolf, Jean-Rene Broussard
Invoking statutory authority not used in almost two decades, President Trump on April 20, 2017, directed the DOC to conduct an investigation into the effects of steel imports on U.S. national security.
By Clark Gordon
First, the petitioner knew of the prior art asserted in the second petition when it filed the first petition.
By Yimeng Dou
Omega Patents, LLC sued CalAmp Corp. for patent infringement in the Middle District of Florida. The jury returned a verdict for Omega, finding all of the asserted claims valid and infringed.
By Thomas Landers IV
On March 20, 2017, a Patent Trial and Appeal Board (PTAB) panel declined to institute an inter partes review (IPR) of patent claims that were also the subject of a previously filed IPR by the same petitioner (IBM).
By John Patrick Clayton, Seth Molay
On Wednesday, April 12, 2017, a final rule became effective that added two new "check box" items to the covers of Securities Act and Exchange Act forms relating to an issuer's status as an emerging growth company.
By Donald R. Pongrace, Hal Shapiro
Congress entered into its spring recess on April 7 having delivered regulatory reforms to President Trump's desk. In the first 75 days of the Trump administration, legislators approved 13 Congressional Review Act resolutions, with President Trump signing 11 thus far.
By Akin Gump Strauss Hauer & Feld LLP
MergerMarket data shows that global deal activity in the first quarter of 2017 has so far remained resilient despite geopolitical uncertainty, with 3,554 deals worth $678.5 billion announced, representing an 8.9% increase in value compared to the first quarter of 2016 (4,326 deals, $622.9 billion).
By John Goodgame, Paul Monsour
We can imagine that many law firm capital markets associates reacted to that news by turning pale and getting nervous, thinking about one fewer day between pricing and closing of a public securities offering.
By Jason Weil
The Patent Trial and Appeal Board issued a final written decision determining that the Coalition for Affordable Drugs (ADROCA), LLC failed to prove unpatentable claims 1-52 of U.S. Patent No. 8,440,703 owned by Acorda Therapeutics, Inc.
By Neal Marder, Ali Rabbani, Andrew Jick, Zak Franklin
McGill then petitioned to the California Supreme Court, which granted review of the Court of Appeal's order.
By Richard Rabin, Desiree Busching, Jeffrey Wiener
Yesterday, the New York City Council passed a bill prohibiting firms from inquiring about, or relying on, an applicant's salary history in connection with the recruiting or hiring process.
By Lars-Erik Hjelm, Hal Shapiro, Jean-Rene Broussard, Suzanne Kane
President Trump signed two EOs addressing trade on Friday, March 31: one addressing trade and customs enforcement, including the collection of antidumping and countervailing duties...
By Melissa Gibson
Finally, the PTAB found that the evidence of secondary considerations in this case supported a finding of nonobviousness.
By Akin Gump Strauss Hauer & Feld LLP
On March 23, 2017, SEC Chairman Nominee Jay Clayton testified before the Senate Banking Committee at his confirmation hearing.
By Donald R. Pongrace, Hal Shapiro
As the Trump presidency completes its first 10 weeks, the administration is celebrating big wins on the regulatory reform front while nursing some wounds from a major defeat on efforts to repeal...
Contributor's Topics